The intestinal microbiota is a vital organ critical to the development, functioning, and health of the human the host. Our research focus is to characterize how disruptions in this community affect the onset and progression of diseases and conditions e.g., obesity, colorectal cancer, and inflammatory bowel diseases. By applying microbial ecology principles and leveraging next-generation sequencing technologies, our goal is to develop targeted, microbiota-based therapies to improve patient outcomes.
Microbial community dynamics related to obesity and type 2 diabetes Fecal microbiota transplantation therapies Patterns of dysbiosis related to health outcomes Network modeling of microbial communities Personalized microbiota therapeutics Microbiota interactions in solid and non-solid cancers
Fellowships, Residencies, and Visiting Engagements
Honors and Recognition
AddressMayo Mail Code 195
420 Delaware St, SE
Minneapolis, MN 55455
Kelli Tourand | 612-624-4581 | email@example.com